04.07.2019 • News

Gelest Boosts Portfolio with Bimax Buy

Gelest Boosts Portfolio with Bimax Buy
Gelest Boosts Portfolio with Bimax Buy

Gelest, a US manufacturer of silicones, organosilanes and metal-organics, has purchased Bimax, a producer of specialty monomers and polymers used to make contact and intraocular lenses, personal care products, coatings and adhesives, among other advanced technology applications. Financial terms of the deal were not disclosed.

Commenting on the acquisition, Ken Gayer, Gelest’s CEO, said:  “Bimax strengthens our position in high-growth value-added applications, provides access to new customers and talent and expands our production capability and R&D pipeline.”

Andre Moura, managing director at Gelest’s majority shareholder New Mountain Capital, added that the two businesses were highly complementary.

Gelest has been a portfolio company of New York-based investment firm New Mountain Capital since March 2017. New Mountain Capital owns a controlling interest in the Morrisville, Pennsylvania-based company, with Gelest’s founder and management team maintaining a “significant” shareholding.

Bimax, which is headquartered in Glen Rock, Pennsylvania, will continue to operate under its own name and will retain all its employees in their current roles.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.